Maribavir

CHEMBL515408 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

376.2 g/mol

LogP

2.2

Phase

4

An antiviral medication used to treat cytomegalovirus (CMV) infections that are resistant or refractory to standard antiviral treatments in transplant recipients, working by inhibiting the viral kinase UL97. It offers an oral treatment option for a serious complication of transplantation.

Masse moléculaire

376,2000 g/mol

LogP

2,20

TPSA

99,80 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Chronic Kidney Disease

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O

InChI

InChI=1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1

Molecular Formula

C15H19Cl2N3O4

HBD / HBA

4 / 6

Liaisons Rotatives

4

Atomes Lourds

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

An antiviral medication used to treat cytomegalovirus (CMV) infections that are resistant or refractory to standard antiviral treatments in transplant recipients, working by inhibiting the viral kinase UL97. It offers an oral treatment option for a serious complication of transplantation.

Yes, Maribavir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL515408. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 471161. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Maribavir sur PillFYI

Structure

Données Clés

Formule: C15H19Cl2N3O4
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.